An investigation of genetic, cognitive and neuroendocrine markers for predicting antidepressant resp

来源 :第十二次全国医学遗传学学术会议 | 被引量 : 0次 | 上传用户:Mr_Zhou
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
  Objective:To test the hypothesis that a tentative integrative model by combining genetics, neuroendocrine and cognition biomarker could predict antidepressant response in depressed patients Method:A total of 365 depressed patients, age 18-55 years, fulfilling the DSM-Ⅳ diagnostic criteria for major depressive disorder, with a minimum HAMD score at 18, were recruited for this study.All patients were randomly assigned into either the SSRI (N=290) or the TCA (N=75) group and received a 6-week period of treatment.Response was defined as a >50% of the reducing scores rate of HAMD scores at the end of the 6th week.Nine single nucleotide polymorphisms (SNPs) in two genes (BDNF, NTRK2) selected from dbSNP (http://www.ncbi.nlm.nih.gov) or previous literature were studied.Result:There were significant association between three SNPS (rs1221, rs716893, rs720141) and response to antidepressant treatment, but only SNP ofrs720141 remained significant after correcting for multiple testes using FDR method.Haplotype analysis revealed that the C-G haplotype of NTRK2 was associated with antidepressant treatment failure (p=0.029).MANOVA analysis showed that there was a significant difference in performance of WCST test between two groups (p<0.05).By using logistic regression, We found that a main effect on predicting treatment response was apparent for rs720141 genotype, the continuous errors number and the scores of negative events (p=0.001, OR=3.155, 95%CI=1.579-6.303; p=0.012, OR=0.967, 95%CI=0.943-0.993; p=0.017, OR-0.990, 95%CI=0.982-0.998, separately).The combination of the three factors revealed the 74.8% explanation for the variance.Conclusion: Combining rs720141 genotype in NTRK2 gene, the continuous errors number in WCST test and scores in negative life events, could be the best predictors for antidepressant response in depressed patients.
其他文献
Background & Aims: Hepatocellular carcinoma (HCC), one of the most common malignant human cancers worldwide, is identified as the third leading cause of cancer-related deaths.The most important risk f
畸形精子症是影响男性不育的重要因素之一,然而其发病机制尚未明晰,以致此类患者不能得到有效治疗。近年来对精子形态的研究取得了一定进展,某些基因被证实与畸形精子的发生有关。对于相关基因的研究,不仅可以从分子水平上更精确地揭示疾病发生发展机制,而且为基因诊断和基因治疗提供理论支持。
Objective The aim of this study was to examine whether the ETS1 single nucleotide polymorphism (SNP) rs1128334 plays a role in systemic lupus erythematosus (SLE) susceptibility in northern Chinese pop
objective To analyze the clinical manifestations and investigate the causative mutation of a Chinese family with X-linked Charcot-Marie-Tooth(CMTX).Methods The clinical, electrophysiologieal and patho
Background: Alcohol dehydrogenase-1B (ADH1B) and aldehyde dehydrogenase-2 (ALDH2) are important enzymes in human alcohol metabolism.The genetic polymorphisms of ADH1B 143G>A (ADH1B*1/ADH1B*2) and ALDH
Objective Orosomucoid-like 3 (ORMDL3) has been associated with asthma and a series of autoimmune disorders and is involved in endoplasmic reticulum-mediated inflammatory responses.Yet, the clinical si
背景与目的 脊髓小脑性共济失调3型/马查多-约瑟夫病(SCA3/MJD)是一类具有明显临床和遗传异质性的神经退行性疾病,目前尚无特效治疗.错误折叠的多聚谷氨酰胺(PolyQ)扩展突变型蛋白的清除障碍是该病的发病机制之一,清除蛋白积聚体可部分延缓疾病的进展.氯化锂作为一种神经保护剂,不仅能通过抑制GSK-3β活性发挥抗凋亡作用,还能通过上调自噬水平加强蛋白积聚体的清除,有望成为治疗本病的药物.本研究
Objective AZFc deletions cause significant phenotypic heterogeneity with respect to spermatogenesis; however, the reason for this is poorly understood.Recently, TSPY1 copy number variation (CNV) was d
Objective Kawasaki disease (KD) is a dominant cause of acquired heart disease in children due to frequent complicating coronary artery lesions (CALs).Genome-wide association study and linkage analysis
Objective Lipoprotein glomerulopathy (LPG) is a rare inherited renal disease caused by mutation of the APOE gene.It is characterized by proteinuria and nephrotic syndrome with elevated serum apoE.The